MRKR financials

Marker Therapeutics (MRKR) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

MRKR income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$3.55M–-$12.89M-$12.16M-0.79
2024$6.59M–-$11.12M-$10.73M-1.19
2023$3.31M–-$14.58M-$8.24M-0.94
2022$3.51M–-$19.79M-$29.93M-3.58
2021$1.24M–-$39.48M-$41.88M-5.47
2020$466.79K–-$28.89M-$28.71M-6.10

Updated 2026-11-20 21:45 UTC